Actelion Pharmaceuticals Ltd / Actelion to publish nine months 2014 financial results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Dear Member of the Investment Community

Actelion Ltd will announce the nine months 2014 financial results on Tuesday, 21 October 2014, at 07.00 hrs CEST / 06.00 hrs BST / 01.00 a.m. EDT.

Results Day Center

All relevant supporting information, such as the media release, financial statement, fact sheets and other related documents and links to updated content will be available in the Results Day Center on the corporate website: www.actelion.com/results-day-center.

Invitation to Conference Call/ Webcast

An investor conference call & webcast will be held at 14.00 hrs, CEST to discuss the results.

 

Date/Time:

21 October 2014 14.00 hrs Basel (CEST)
  13.00 hrs UK (BST)
  08.00 a.m US (EDT)


Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.

Dial: Europe: +41 (0) 22 580 29 91
  UK: +44 (0) 207 108 6206
  US: +1 866 305 6290

 

Participant's mode:

Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.

Webcast Access:

Webcast participants should visit the Actelion website http://www.actelion.com:
http://www.actelion.com/
10-15 minutes before the conference is due to start.

Participant's mode:

Listen-Only

           

Webcast Replay:

The archived Investor Webcast will be available for replay through http://www.actelion.com:
http://www.actelion.com/  approximately 60 minutes after the call has ended.  


Invitation PDF:
http://hugin.info/131801/R/1862736/653567.pdf


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire
HUG#1862736

--- End of Message ---

Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland

ISIN: CH0010532478;